Recent evidence points to important contributions of exposure to environmental neurotoxicant chemicals in the marked increase in neurodevelopmental disorders, including learning disabilities, attention deficit and hyperactivity disorder, and autism spectrum disorders ([@b75-ehp0115-000093]). Despite the increasing recognition of the importance of evaluating developmental neurotoxicity in safety assessment ([@b16-ehp0115-000093]; [@b25-ehp0115-000093]; [@b80-ehp0115-000093], [@b81-ehp0115-000093]), the fact remains that, of \> 70,000 commercial chemicals in current use, neurotoxicity of any kind has been evaluated in \< 10% ([@b42-ehp0115-000093]), and obviously, developmental neurotoxicity in a substantially smaller fraction. Even now, of the 2,000--3,000 new chemicals released each year, two-thirds never get tested for neurotoxicity, let alone developmental effects ([@b16-ehp0115-000093]), whereas between 25--40% will eventually prove to be neurotoxic ([@b10-ehp0115-000093]). Among the many potential developmental neurotoxicants, the greatest attention has been paid to pesticides, in light of their widespread use in the home and in agriculture \[[@b84-ehp0115-000093]\]. Here, too, despite the institution of a standardized protocol for developmental neurotoxicity, few compounds have actually been tested relative to the total number of concern, even after mandated call-ins for data by the U.S. EPA ([@b47-ehp0115-000093]; [@b84-ehp0115-000093]).

A number of factors contribute to the dearth of information on developmental neurotoxicity relative to the demonstrated need for such knowledge. First, there is the essential dichotomy between the requirement to evaluate large numbers of compounds and the costly, cumbersome protocols prescribed for standard tests in animals ([@b17-ehp0115-000093]; [@b47-ehp0115-000093]; [@b65-ehp0115-000093]; [@b84-ehp0115-000093]). Second, testing compounds one at a time may produce results that are difficult to compare ([@b17-ehp0115-000093]; [@b84-ehp0115-000093]), in large measure because the presumed mechanisms and targets are based on systemic or central nervous system effects in adults that may be unrelated to developmental neurotoxicity ([@b17-ehp0115-000093]; [@b47-ehp0115-000093]; [@b65-ehp0115-000093], [@b66-ehp0115-000093]). The organophosphate insecticides provide an archetype. Although it was originally thought that all organophosphates act similarly through irreversible inhibition of acetylcholinesterase, it is now evident that their adverse effects on brain development actually involve multiple mechanisms, many of which are unrelated to cholinesterase inhibition ([@b15-ehp0115-000093]; [@b19-ehp0115-000093]; [@b57-ehp0115-000093]; [@b64-ehp0115-000093], [@b65-ehp0115-000093], [@b66-ehp0115-000093]). Accordingly, the relative potencies of organophosphates toward cholinesterase inhibition and/or systemic toxicity do not necessarily correlate with their propensity to elicit developmental neurotoxicity ([@b19-ehp0115-000093]; [@b57-ehp0115-000093]; [@b58-ehp0115-000093]; [@b67-ehp0115-000093], [@b71-ehp0115-000093]).

One strategy proposed to resolve this problem is the use of screening techniques based on cell culture systems or lower organisms as the first stage of evaluation, thus enabling subsequent animal studies to focus on those compounds most likely to cause developmental neurotoxicity ([@b18-ehp0115-000093]; [@b65-ehp0115-000093]). This approach was recently endorsed in a report from the Inspector General of the U.S. EPA ([@b54-ehp0115-000093]) as well as by outside groups ([@b17-ehp0115-000093]; [@b18-ehp0115-000093], [@b19-ehp0115-000093]; [@b65-ehp0115-000093]). In the present study we use PC12 cells, a standard *in vitro* model for neuronal development ([@b76-ehp0115-000093]) that has already been used to characterize essential features of the developmental neurotoxicity of organophosphates ([@b5-ehp0115-000093], [@b6-ehp0115-000093]; [@b21-ehp0115-000093], [@b22-ehp0115-000093]; [@b24-ehp0115-000093]; [@b27-ehp0115-000093]; [@b38-ehp0115-000093]; [@b44-ehp0115-000093]; [@b53-ehp0115-000093]; [@b58-ehp0115-000093], [@b59-ehp0115-000093]; [@b73-ehp0115-000093]; [@b83-ehp0115-000093]). As transformed cells, the PC12 line has an advantage over cultured primary neurons, which do not maintain cell division and thus cannot detect adverse effects on the cell cycle, a likely neurotoxic target; furthermore, primary neurons do not provide a uniform population either in terms of cell types or differentiation state, rendering their use for screening problematic. Upon exposure to nerve growth factor (NGF), PC12 cells gradually exit the mitotic cycle and begin to differentiate, developing axonal projections, electrical excitability, and the characteristics of two distinct phenotypes, cholinergic and catecholaminergic neurons ([@b28-ehp0115-000093]; [@b73-ehp0115-000093]; [@b76-ehp0115-000093]). Accordingly, the PC12 model enables the detection of toxicant actions that target cell replication as well as the events involved in differentiation and the phenotypic emergence of specific neuronal features. The PC12 model has been used to characterize the potential neurotoxicity of a wide variety of compounds in addition to the organophosphates, including nicotine, metals, and organometals ([@b1-ehp0115-000093]; [@b9-ehp0115-000093]; [@b20-ehp0115-000093]; [@b48-ehp0115-000093]; [@b56-ehp0115-000093]; [@b62-ehp0115-000093]; [@b79-ehp0115-000093]); largely, these have been done one compound or class at a time and with a focus on individual cellular targets or processes, rather than within a framework of comparative changes with a global impact on neurodevelopment. Critical for the use of PC12 cells in modeling the developmental neurotoxicity of compounds such as the organophosphates, the cholinergic and catecholaminergic phenotypes are among the prominent *in vivo* targets for these compounds ([@b2-ehp0115-000093]; [@b7-ehp0115-000093]; [@b23-ehp0115-000093]; [@b38-ehp0115-000093]; [@b57-ehp0115-000093]; [@b61-ehp0115-000093]; [@b64-ehp0115-000093]; [@b69-ehp0115-000093]; [@b87-ehp0115-000093]). Nevertheless, PC12 cells share the limitations common to *in vitro* models, namely an inability to assess neuronal--glial interactions or architectural aspects of regional development, maternal--fetal or neonatal pharmacokinetics, and related issues of bioavailability, dose, and bioeffective concentrations ([@b18-ehp0115-000093]; [@b65-ehp0115-000093]).

Although chlorpyrifos has been the most studied compound in the PC12 model ([@b5-ehp0115-000093], [@b6-ehp0115-000093]; [@b21-ehp0115-000093], [@b22-ehp0115-000093]; [@b24-ehp0115-000093]; [@b38-ehp0115-000093]; [@b58-ehp0115-000093], [@b59-ehp0115-000093]; [@b73-ehp0115-000093]), similarities and differences have been noted for other organophosphates such as diazinon and for nonorganophosphate cholinesterase inhibitors of the carbamate class, with physostigmine as the prototype ([@b38-ehp0115-000093]; [@b58-ehp0115-000093]). In the present work, we compared chlorpyrifos, diazinon, and a third organophosphate (parathion) with physostigmine, an organochlorine (dieldrin), and a metal (Ni^2+^).These additional compounds were chosen for specific mechanistic and environmental reasons. First, all of them except physostigmine appear on the registry of Superfund Chemicals ([@b85-ehp0115-000093]) and thus represent significant disposal problems. For diazinon, exposures of inner-city women during pregnancy are comparable to those seen with chlorpyrifos ([@b92-ehp0115-000093]). The developmental neurotoxicity of diazinon has been studied sparingly, but shows a spectrum of effects similar to chlorpyrifos in both the PC12 model ([@b4-ehp0115-000093]; [@b58-ehp0115-000093]) and in evaluations with lower organisms ([@b51-ehp0115-000093]), albeit with a potency profile differing from the comparative effects of the two organophosphates on cholinesterase ([@b67-ehp0115-000093]). For parathion, despite U.S. restrictions, use and exposure remain common in agricultural communities around the world ([@b26-ehp0115-000093]). With chronic exposure to frankly toxic doses, parathion inhibits protein synthesis in the fetus ([@b31-ehp0115-000093]), whereas at lower exposures, it displays developmental toxicity that is not dependent on cholinesterase inhibition per se ([@b3-ehp0115-000093]) but rather reflects differences in neural adaptations to exposure ([@b35-ehp0115-000093]; [@b39-ehp0115-000093]; [@b46-ehp0115-000093]). However, compared with chlorpyrifos and diazinon, parathion exhibits greater systemic toxicity relative to its propensity to produce developmental neurotoxicity ([@b67-ehp0115-000093]), again echoing the view that organophosphates are distinct in their profiles for adverse effects on the immature brain. Although the effects of parathion have not been evaluated in PC12 cells in a developmental context, other neural culture systems have successfully recapitulated the adverse effects on neurodevelopment and confirmed its dissociation from mechanisms involving cholinesterase inhibition ([@b50-ehp0115-000093]; [@b98-ehp0115-000093]). The carbamate physostigmine is effective as a cholinesterase inhibitor and shares some organophosphate-like effects on cell differentiation, but it is much less capable of eliciting immediate antimitotic actions ([@b38-ehp0115-000093]; [@b58-ehp0115-000093]); it is considerably less effective than organophosphates as a developmental neurotoxicant in lower organisms ([@b13-ehp0115-000093]).

In contrast to the organophosphates, organochlorines such as dieldrin have been less studied for developmental neurotoxicity, but the available evidence suggests a much more restricted range of mechanisms. Acute dieldrin intoxication produces fetal neural damage ([@b86-ehp0115-000093]), and at lower concentrations, dieldrin interacts with γ-amino butyric acid (GABA~A~) channels in the fetal brain ([@b12-ehp0115-000093]); however, the long-term consequences of these lower-dose effects have not been evaluated. We suspect that the same strategies adopted for studies of organophosphates at the cellular level might prove useful in uncovering biomarkers and mechanisms for developmental neurotoxicity of dieldrin; for example, short-term, high-concentration dieldrin exposure of PC12 cells elicits oxidative stress and apoptosis differentially according to neurotransmitter phenotype ([@b40-ehp0115-000093], [@b41-ehp0115-000093]). Similarly, nickel compounds readily cross the placenta and accumulate in fetal tissues, including the brain, at concentrations that greatly exceed maternal levels ([@b36-ehp0115-000093]). Indeed, the nickel concentration just from normal dietary and environmental exposure in human fetuses is comparable to that of lead, up to 2 μg/g dry weight in soft tissues including the brain ([@b14-ehp0115-000093]). Although the developmental neurotoxicity of nickel is almost completely unexplored, there is every reason to believe this metal may be as injurious as lead. In PC12 cells, Ni^2+^ interferes with the gating of calcium just as does lead or cadmium ([@b9-ehp0115-000093]) in a manner that is dependent on the state of differentiation of the cells, so that the inclusion or exclusion of NGF makes a great difference in susceptibility ([@b54-ehp0115-000093]). In developing sea urchins, Ni^2+^ produces phenotypic abnormalities that bear some resemblance to those caused by the organophosphates ([@b13-ehp0115-000093]; [@b32-ehp0115-000093]).

Our overall strategy was to focus on aspects of neurodevelopment that lend themselves to rapid screening and that permit ready comparisons of targets involving cell replication, growth, and differentiation. We compared the effects of different concentrations and durations of exposure of PC12 cells to chlorpyrifos, diazinon, parathion, physostigmine, dieldrin, and Ni^2+^ in undifferentiated and differentiated states, evaluating indices of cell replication (radiolabeled thymidine incorporation into DNA), cell number, cell growth, viability (trypan blue exclusion), and phenotype. Each neural cell contains only a single nucleus ([@b93-ehp0115-000093]), so that the DNA content (micrograms of DNA per culture dish in the present study) reflects the total number of cells ([@b73-ehp0115-000093]). Indices of growth were provided by measurements of protein subfractions related to cell size and membrane surface area ([@b37-ehp0115-000093]; [@b77-ehp0115-000093]). The total protein/DNA ratio rises with cell enlargement, and the membrane/total protein ratio falls as a consequence of the decreased surface-to-volume ratio. On the other hand, with the onset of differentiation, the development of neuritic projections necessitates a rise in the relative contribution of membrane proteins, so that the increase in the membrane/total protein ratio gives an indication of augmented membrane "complexity." The effects on cell number, size, and cell surface area were compared to those on viability (evaluated by trypan blue exclusion) and lipid peroxidation (evaluated by thiobarbituric acid-reactive species; TBARS). To characterize the catecholaminergic and cholinergic phenotypes, we assessed the ratio of activities of tyrosine hydroxylase (TH) to choline acetyltransferase (ChAT), the respective biosynthetic enzymes for dopamine and acetylcholine ([@b76-ehp0115-000093]; [@b37-ehp0115-000093], [@b38-ehp0115-000093]).

Materials and Methods
=====================

Cell cultures
-------------

Because of the clonal instability of the PC12 cell line ([@b28-ehp0115-000093]), the experiments were performed on cells that had undergone fewer than five passages, and all studies were repeated several times with different batches of cells. As described previously ([@b21-ehp0115-000093]; [@b60-ehp0115-000093]; [@b73-ehp0115-000093]), PC12 cells (1721-CRL; American Type Culture Collection, Manassas, VA) were seeded onto 100-mm poly-[d]{.smallcaps}-lysine-coated plates in RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% inactivated horse serum (Sigma Chemical Co., St. Louis, MO), 5% fetal bovine serum (Sigma Chemical Co.), and 50 μg/mL penicillin streptomycin (Invitrogen). Cells were incubated with 7.5% CO~2~ at 37°C, and the medium was changed every 2 days. For studies in the undifferentiated state, cells were seeded at varying densities so that, regardless of the total time of incubation, the cells would reach a final confluence of 60--70%. Twenty-four hours after seeding, the medium was changed to include the various test substances: chlorpyrifos (Chem Service, West Chester, PA), diazinon (Chem Service), parathion (Chem Service), physostigmine (Sigma Chemical Co.), dieldrin (Chem Service), or NiCl~2~ (Sigma Chemical Co.). Because of their poor water solubility, the pesticides were dissolved in dimethyl sulfoxide (Sigma Chemical Co.), achieving a final concentration of 0.1% in the culture medium; accordingly, all cultures included this vehicle, which had no effect on the PC12 cells ([@b58-ehp0115-000093], [@b60-ehp0115-000093]; [@b73-ehp0115-000093]).

For studies in differentiating cells, 3 × 106 cells were seeded; 24 hr later, the medium was changed to include 50 ng/mL 2.5 S murine NGF (Invitrogen), and each culture was examined under a microscope to verify the subsequent outgrowth of neurites. The test agents were added concurrently with the start of NGF treatment.

DNA synthesis
-------------

To initiate the measurement of DNA synthesis, the medium was changed to include 1 μCi/mL of \[^3^H\]thymidine (specific activity, 2 Ci/mmol; GE Healthcare, Piscataway, NJ) along with the continued inclusion of the test substances. After 1 hr, the medium was aspirated and cells were harvested in ice-cold water. Duplicate aliquots of each sample were treated with 10% trichloroacetic acid and sedimented at 1,000 × *g* for 15 min to precipitate macromolecules. The resulting pellet was washed once with additional trichloroacetic acid and then with 75% ethanol. The final pellet was hydrolyzed with 1 M KOH overnight at 37°C and neutralized with 6 M HCl, and the DNA was precipitated with ice-cold 5% trichloro-acetic acid and resedimented. The supernatant solution, comprising solubilized RNA and protein, was discarded. The DNA-containing pellet was hydrolyzed in 5% trichloroacetic acid for 15 min at 90°C and resedimented, and an aliquot of the supernatant solution was counted for radiolabel. Another aliquot was assayed for DNA spectrophotometrically by absorbance at 260 nm. Previous work has demonstrated quantitative recovery of DNA by these techniques ([@b8-ehp0115-000093]; [@b68-ehp0115-000093]). Incorporation values were corrected to the amount of DNA present in each culture to provide an index of macromolecule synthesis per cell ([@b93-ehp0115-000093]).

Cell number and size
--------------------

For determinations of DNA content, total protein/DNA ratio and membrane/total protein ratio, the medium was aspirated and the culture was rinsed with a buffer consisting of 154 mM NaCl and 10 mM sodium phosphate (pH 7.4). Cells were harvested in ice-cold buffer and homogenized (Polytron; Brinkmann Instruments, Westbury, NY), and aliquots were withdrawn for measurements of DNA and total protein using dye-binding methods ([@b82-ehp0115-000093]). To prepare the cell membrane fraction, the homogenates were sedimented at 40,000 × *g* for 10 min and the pellet was washed and resedimented. Aliquots of the final resuspension were then assayed for membrane protein ([@b72-ehp0115-000093]).

Enzyme activities
-----------------

Cells were harvested as described above and were disrupted by homogenization in a ground-glass homogenizer fitted with a ground-glass pestle, using a buffer consisting of 154 mM NaCl and 10 mM sodium-potassium phosphate (pH 7.4). Aliquots were withdrawn for measurement of DNA and protein ([@b72-ehp0115-000093]).

ChAT assays ([@b43-ehp0115-000093]) were conducted in 60 μL of a buffer consisting of 60 mM sodium phosphate (pH 7.9), 200 mM NaCl, 20 mM choline chloride, 17 mM MgCl~2~, 1 mM EDTA, 0.2% Triton X-100, 0.12 mM physostigmine, and 0.6 mg/mL bovine serum albumin (Sigma Chemical Co.), containing a final concentration of 50 μM \[^14^C\]acetyl-coenzyme A (specific activity 60 mCi/mmol, diluted with unlabeled compound to 6.7 mCi/mmol; PerkinElmer Life Sciences, Boston, MA). The amount of protein used in each assay was adjusted to maintain activity within the linear range. Blanks contained homogenization buffer instead of the tissue homogenate. Samples were pre-incubated for 15 min on ice and transferred to a 37°C water bath for 30 min; the reaction was terminated by placing the samples on ice. Labeled acetylcholine was then extracted and counted in a liquid scintillation counter and the activity was calculated as nanomoles synthesized per hour per microgram DNA.

TH activity was measured using \[^14^C\]tyrosine as a substrate and trapping the evolved ^14^CO~2~ after coupled decarboxylation with dopa decarboxylase ([@b43-ehp0115-000093]; [@b88-ehp0115-000093]). Homogenates were sedimented at 26,000 × *g* for 10 min to remove storage vesicles containing catecholamines, which interfere with TH activity, and assays were conducted with 100 μL aliquots of the supernatant solution in a total volume of 550 μL. Each assay (pH 6.1) contained final concentrations of 910 μM FeSO~4~, 55 μM unlabeled L-tyrosine (Sigma Chemical Co.), 9.1 μM pyridoxal phosphate (Sigma Chemical Co.), 36 μM β-mercaptoethanol, and 180 μM 2-amino-6,7-dimethyl-4-hydroxy-5,6,7,8-tetrahydropteridine HCl (Sigma Chemical Co.), all in a buffer of 180 mM sodium acetate and 1.8 mM sodium phosphate (pH 6.1). Each assay contained 0.5 μCi of generally labeled \[^14^C\]tyrosine (specific activity, 438 mCi/mmol; Sigma Chemical Co.) as substrate, and blanks contained buffer in place of the homogenate. Activity was calculated on the same basis as for ChAT.

Thiobarbituric acid-reactive species
------------------------------------

TBARS determinations were carried out by a modification ([@b59-ehp0115-000093]) of published procedures ([@b29-ehp0115-000093]). Cells were harvested with 150 mM NaCl and 10 mM sodium phosphate (pH 7.4) and sonicated for 20 sec; aliquots were withdrawn for measurements of DNA and protein ([@b72-ehp0115-000093]; [@b82-ehp0115-000093]). Another aliquot was added to 0.5 volumes of 15% trichloroacetic acid, followed by 1.5 volumes of thiobarbituric acid reagent: 0.67 g thiobarbituric acid (Sigma Chemical Co.) dissolved in 80 mL of 1 M NaOH, titrated to pH 3.5 with 20 mL glacial acetic acid. Samples were incubated for 60 min at 90--100°C, cooled to room temperature, and sedimented at 3,000 × *g* for 10 min. The supernatant solution was resedimented and absorption was determined at 532 nm, using malonaldehyde bis(dimethylacetal) (Sigma Chemical Co.) as a standard. To give the TBARS concentration per cell, values were calculated relative to the amount of DNA.

Viability
---------

To assess cell viability, the cell culture medium was changed to include trypan blue (1 volume per 2.5 volumes of medium; Sigma Chemical Co.) and cells were examined for staining under 400× magnification, counting an average of 100 cells per field in four different fields per culture.

Data analysis
-------------

Data are presented as means and standard errors. For each type of study, treatment differences were first evaluated with a global analysis of variance (ANOVA; data log-transformed whenever variance was heterogeneous) incorporating all variables: cell batch number, treatment, and time. Based on the main treatment effects and/or interactions of treatment × time, differences for individual treatments were evaluated post hoc by Fisher's protected least significant difference. For all tests, significance was assumed at *p* \< 0.05. In the initial test, the results did not vary among the different batches of cells, so results across the different batches were combined for presentation and the indicated number of samples in each experiment reflects the total number of cultures.

Results
=======

In undifferentiated PC12 cells, even a 1-hr exposure to a low concentration (5 μM) of each of the agents elicited a small but statistically significant reduction in the rate of cell replication as monitored by the incorporation of \[^3^H\]thymidine into DNA ([Figure 1A](#f1-ehp0115-000093){ref-type="fig"}). Among the organophosphates, diazinon and parathion were slightly more effective than chlorpyrifos (e.g., at 1 hr of exposure, *p* \< 0.03 for diazinon or parathion vs. chlorpyrifos); for the other agents, physostigmine and dieldrin were similar to diazinon, whereas Ni^2+^ was only about as effective as chlorpyrifos (*p* \< 0.03 for Ni^2+^ vs. diazinon). We then evaluated whether the response was maintained with continued exposure to the organophosphates. After 24 hr exposure, all the compounds remained effective; nevertheless, the response to parathion disappeared after 4--6 days of continuous exposure, whereas the effects of chlorpyrifos and diazinon remained detectable. Raising the concentration to 30 μM produced correspondingly more robust inhibition of DNA synthesis in undifferentiated cells ([Figure 1B](#f1-ehp0115-000093){ref-type="fig"}). Again, diazinon remained more effective than chlorpyrifos with 1 hr of exposure (*p* \< 0.0001), and this relationship remained over a span of 6 days. At this higher concentration, the effect of parathion was maintained throughout the exposure period. However, physostigmine showed adaptation by 4 days of exposure, whereas the adverse effects of the organophosphates, dieldrin, and Ni^2+^ remained fully in evidence.

In cells undergoing NGF-induced differentiation, the rate of DNA synthesis was far lower than in undifferentiated cells and declined precipitously over the span of 12 days ([Figure 1C](#f1-ehp0115-000093){ref-type="fig"}, note change in ordinate scale). Nevertheless, inhibitory effects of the organophosphates and physostigmine were fully in evidence after 4 days of coexposure with NGF. Unlike the situation in undifferentiated cells, the response to physostigmine did not show attenuation with continued exposure and, in fact, the carbamate had a greater effect than did the organophosphates (*p* \< 0.02 vs. chlorpyrifos; *p* \< 0.005 vs. diazinon; *p* \< 0.0008 vs. parathion).

In keeping with their ability to inhibit DNA synthesis, all the test agents produced significant shortfalls in cell number when undifferentiated cells were exposed for a period of 6 days ([Figure 2A](#f2-ehp0115-000093){ref-type="fig"}). Chlorpyrifos and diazinon each elicited a reduction of about 10%, whereas parathion was somewhat more effective (*p* \< 0.01 vs. either chlorpyrifos or diazinon) and physostigmine substantially more so (*p* \< 0.0001 vs. chlorpyrifos or diazinon; *p* \< 0.004 vs. parathion). Dieldrin and Ni^2\ +^ had effects similar to those of the organophosphates. In contrast, cell growth was not suppressed by the organophosphates or physostigmine and, in fact, there were significant elevations in the total protein/DNA ratio for these agents ([Figure 2B](#f2-ehp0115-000093){ref-type="fig"}). For this index, there were clear differences between these compounds and dieldrin or Ni^2+^, both of which evoked a significant reduction in the total protein/DNA ratio. In keeping with a reduction in cell size for these two agents, the membrane/total protein ratio rose, reflecting the higher surface/volume ratio associated with smaller cells ([Figure 2C](#f2-ehp0115-000093){ref-type="fig"}). Paradoxically, chlorpyrifos, parathion, and physostigmine increased the membrane/total protein ratio, despite the fact that they also increased the total protein/DNA ratio, implying that these agents actually augmented the membrane complexity of the cells as an accompaniment to the increase in cell size. Diazinon did not share these properties.

We next conducted parallel studies for bio-markers of cell number and size in differentiating cells at 4 and 8 days of exposure. All of the agents elicited significant decrements in cell number across both time points ([Figure 3A](#f3-ehp0115-000093){ref-type="fig"}). With the exception of Ni^2+^, the adverse effects worsened substantially between 4 and 8 days and were much greater in magnitude than the deficits seen in undifferentiated cells (note different scales for [Figure 2A](#f2-ehp0115-000093){ref-type="fig"} and [3A](#f3-ehp0115-000093){ref-type="fig"}). Again, we did not see evidence for additional impairment of cell growth: all agents increased the total protein/DNA ratio significantly, with a correspondingly greater effect at 8 days, when cell number was reduced the most ([Figure 3B](#f3-ehp0115-000093){ref-type="fig"}). On the other hand, there were biphasic effects on the membrane/total protein ratio in differentiating cells ([Figure 3C](#f3-ehp0115-000093){ref-type="fig"}). At 4 days of exposure, the organophosphates had little or no effect on this marker, whereas physostigmine, dieldrin, and Ni^2+^ all elicited a significant reduction. After 8 days of continuous exposure, the differentiating cells showed increases in the membrane/total protein ratio for chlorpyrifos, parathion, and dieldrin, whereas the other three agents had no significant effect.

In differentiating cells after 6 days of co-exposure to NGF and each agent, there were no significant effects on trypan blue exclusion ([Figure 4A](#f4-ehp0115-000093){ref-type="fig"}) and the proportion of nonviable cells was uniformly low in all preparations. In contrast, we obtained evidence for significant membrane lipid peroxidation, as evidenced by the TBARS assay ([Figure 4B](#f4-ehp0115-000093){ref-type="fig"}). All of the organophosphates, as well as physostigmine and dieldrin, evoked significant elevations in TBARS, whereas Ni^2+^ uniquely caused a reduction. Nevertheless, all the agents produced a shift away from the cholinergic phenotype and toward the catecholaminergic phenotype, as evidenced by a significant increase in the TH/ChAT ratio ([Figure 4C](#f4-ehp0115-000093){ref-type="fig"}); similar results for chlorpyrifos and physostigmine have been published previously ([@b38-ehp0115-000093]).

Discussion
==========

One of the major concerns about developmental neurotoxicity is the fact that the targeting of the immature brain may occur at toxicant exposures that are nonsymptomatic or that do not elicit general signs of systemic or cytotoxicity ([@b10-ehp0115-000093]; [@b84-ehp0115-000093]). In the present study, we focused on exposures of PC12 cells to organophosphates, a carbamate, an organochlorine, and a metal that did not by themselves elicit general cytotoxic damage as monitored by trypan blue exclusion. Furthermore, even the 30 μM concentration used for most of our studies lies within the 100--1,000× safety factor required for establishing neurotoxic end points ([@b10-ehp0115-000093]; [@b84-ehp0115-000093]); indeed, for the organophosphates, fetal exposures in agricultural communities are likely to be nearly as high ([@b55-ehp0115-000093]), and similarly, even routine dietary intake produces brain Ni^2+^ concentrations approximating 10 μM ([@b14-ehp0115-000093]). There are three essential findings in our study. First, a single agent may target multiple events in neural cell replication and differentiation, thus spanning a wide range of developmental stages. Second, otherwise unrelated chemicals that likely possess different originating mechanisms of action can nevertheless converge on a common set of final events in cell development, producing similar outcomes. Finally, and perhaps most importantly, our evaluations show the potential utility of an approach using neuronotypic cells in culture to screen suspected developmental neurotoxicants, enabling characterization of vulnerable stages, likely outcomes, and rank comparisons of related and unrelated chemicals.

In our earlier work with organophosphates, we demonstrated the ability of chlorpyrifos to cause immediate inhibition of cell replication in undifferentiated PC12 cells, exemplified by a reduction in \[^3^H\]thymidine incorporation into DNA within the first hour of exposure ([@b73-ehp0115-000093]), an effect that mirrors similar actions on the developing brain *in vivo* ([@b91-ehp0115-000093]) and that ultimately leads to deficits in neural cell numbers ([@b64-ehp0115-000093], [@b65-ehp0115-000093], [@b66-ehp0115-000093]), just as seen here in the PC12 model. The effect was shared by another organophosphate (diazinon), whereas a carbamate (physostigmine) was much less effective ([@b58-ehp0115-000093]). Importantly, chlorpyrifos oxon had a lesser action than chlorpyrifos, despite the fact that it is 1,000-fold more potent toward inhibition of cholinesterase ([@b24-ehp0115-000093]). Furthermore, cholinergic antagonists failed to block the effect ([@b73-ehp0115-000093]), demonstrating that the adverse actions of organophosphates on cell replication were separate from anticholinesterase activity. Here, we expanded our findings to include another organophosphate (parathion), an organochlorine (dieldrin), and a metal (Ni^2+^); compared effects at a threshold concentration of 5 μM, as well as at 30 μM; determined the persistence over a course of nearly 1 week of exposure; and evaluated the downstream consequences for cell acquisition and growth. Although all the organophosphates evoked significant reductions in DNA synthesis, diazinon was the most effective over a prolonged time course: after 6 days of continuous exposure, diazinon maintained a significantly greater inhibitory effect than did either chlorpyrifos or parathion. Interestingly, this differs from the rank order of effects at 1 hr in PC12 cells incubated without the inclusion of serum proteins ([@b58-ehp0115-000093]), where chlorpyrifos is more effective than diazinon. It is important to note that the organophosphates show strong binding to serum proteins both *in vivo* and *in vitro* ([@b11-ehp0115-000093]; [@b58-ehp0115-000093]), which reduces their bioeffective concentrations. The effect is highest for chlorpyrifos, less important for parathion, even lower for diazinon, and lowest for physostigmine ([@b11-ehp0115-000093]; [@b74-ehp0115-000093]; [@b90-ehp0115-000093]; [@b94-ehp0115-000093]). For the present study, serum proteins could not be deleted from the medium because they are required to maintain cell growth and viability, and consequently, the rank order of effects changes so that diazinon and physostigmine, with their lower binding, exert greater net effects than would otherwise be expected. These are not unimportant details: the actions of the organophosphates and carbamates *in vivo* are clearly modified by their binding to serum proteins in the circulation. Also, the concentration of these proteins is lower in the fetus than in the adult ([@b78-ehp0115-000093]; [@b95-ehp0115-000093]), so that at comparable concentrations of each neurotoxicant, the fetus will bear a disproportionate burden of adverse effects. Additional factors must be operating to distinguish among the effects of the different organophosphates. For example, we found that the ability of parathion to reduce DNA synthesis at a low concentration (5 μM) showed eventual adaptation, so by 4--6 days of continuous exposure, its inhibitory actions were no longer evident. In contrast, chlorpyrifos and diazinon showed persistence of the effect. Again, these findings illustrate that the PC12 model can incorporate factors such as protein binding that are critical issues for the developmental neurotoxicity of disparate compounds *in vivo*. Based on these findings, it might be anticipated that the various organophosphates will differ from each other and from the carbamates in their adverse effects on brain development, a prediction that should be pursued in future studies.

Given that organophosphates reduce DNA synthesis in undifferentiated cells in a manner different from their ability to inhibit cholinesterase ([@b58-ehp0115-000093]; [@b73-ehp0115-000093]), it is of considerable import that we obtained a similar result with either dieldrin or Ni^2+^, compounds otherwise unrelated to each other, the organophosphates, or physostigmine. This, too, illustrates how disparate neurotoxicants can nevertheless converge on a common set of functional end points and thus may share many of the same attributes for adverse effects on the developing brain *in vivo*. In the present study, the consequences were examined through a series of markers related to cell acquisition and growth. In the undifferentiated cells, 6 days of continuous exposure to each of the agents produced a corresponding decrement in the total number of cells as monitored by DNA content. However, the rank order did not correspond one-to-one with the relative effects on DNA synthesis. For cell acquisition, physostigmine had the greatest adverse effect, followed by parathion, dieldrin, and then by chlorpyrifos ≈diazinon ≈Ni^2+.^ Accordingly, there must be other actions of these agents that influence the total number of cells other than their effect on DNA synthesis. These may include other, rate-limiting steps in the production of new cells downstream from DNA synthesis per se, as well as effects on cell turnover and/or apoptotic loss. We did not observe any decreases in viability as monitored with trypan blue, but a small, persistent adverse effect could eventually influence cell number without being detectable with this technique. Studies are currently under way to examine potentially subtle cytotoxic effects or apoptotic events using gene expression profiling, an approach that may be successful in elucidating these additional mechanisms. However, again, the main point is that a relatively facile set of markers in PC12 cells can detect adverse effects on neural cell acquisition across a wide array of disparate compounds in a short period of time.

In contrast to their effects on cell number, the organophosphates and physostigmine did not suppress cell growth in undifferentiated PC12 cells, as monitored by the protein/DNA ratio; in fact, each of these agents evoked a small but statistically significant increase. On the other hand, both dieldrin and Ni^2+^ did reduce the ratio, implying that these agents simultaneously suppress neural cell acquisition and cell growth. Again, this *in vitro* test system now points the way toward end points that may differentiate the developmental neurotoxicity of these two agents from those of the organophosphates or carbamates. Finally, the assessment of membrane complexity in undifferentiated cells (membrane/total protein ratio) indicated further differences among the agents, with significant increases for all except diazinon. For dieldrin and Ni^2+^, the increase in the ratio reflects in part the inhibition of cell growth, because the geometry of a smaller cell necessitates a higher surface-to-volume ratio. However, that cannot explain the increase for chlorpyrifos, parathion, and physostigmine, which did not suppress cell growth; for these agents, either intracellular organelles are being induced or, alternatively, they may provide a prodifferentiation signal that elicits expansion of the membrane surface as a prelude to neurite outgrowth. Again, this is in keeping with some of the known effects of chlorpyrifos, which can promote dendritic arborization at the expense of axon formation ([@b34-ehp0115-000093]); our findings suggest that diazinon may be distinctly different from chlorpyrifos in that regard. Potentially, these possibilities can be resolved with detailed morphologic techniques, but those hardly lend themselves to rapid screening.

With the initiation of differentiation upon addition of NGF to the cultures, the spectrum of actions of the various agents underwent a distinct transition. For DNA synthesis, the rate of \[^3^H\]thymidine incorporation fell precipitously, as would be expected from the transition from cell replication to differentiation. During the transition, we again compared the organophosphates to physostigmine; although all the agents still produced significant inhibition of DNA synthesis, physostigmine now became the most effective of the agents and, unlike the situation in undifferentiated cells, did not show an adaptive loss of effect. This pattern is consistent with *in vivo* findings, which indicate that the effects of organophosphates on DNA synthesis undergo a switch from noncholinergic to cholinergic mechanisms as differentiation proceeds ([@b63-ehp0115-000093], [@b64-ehp0115-000093], [@b65-ehp0115-000093], [@b66-ehp0115-000093]; [@b91-ehp0115-000093]). Physostigmine, like the organophosphates, is a cholinesterase inhibitor; therefore, under these circumstances, the most relevant factor may simply be the much lower binding of physostigmine to serum proteins, which makes its bioeffective concentration higher than that of the organophosphates ([@b90-ehp0115-000093]). Despite the fact that the overall rate of DNA synthesis was far lower in differentiating cells, prolonged exposure to any of the agents reduced the total number of cells as monitored by DNA content. Again, the effect on DNA synthesis could not explain the rank order of effects on cell number, for which the greatest effects were seen with chlorpyrifos and dieldrin, each of which reduced cell number by about 40%, followed by diazinon, parathion and physostigmine, with Ni^2+^ providing the smallest reduction. Notably, despite the fact that the DNA synthetic rate was lower in differentiating cells than in the undifferentiated state, the magnitude of the effects on cell number were greater during differentiation and, consequently, other factors contribute to the cell deficits. In earlier work with chlorpyrifos, we showed that the peak period of sensitivity occurs at the initiation of differentiation, where actions are exerted simultaneously through noncholinergic and cholinergic mechanisms ([@b38-ehp0115-000093]; [@b58-ehp0115-000093]). Accompanying the reduction in cell numbers, there was an increase in cell size (protein/DNA ratio) for each agent, again suggesting that in differentiating cells---as in undifferentiated cells---there is no direct suppression of cell growth, nor was there evidence for loss of viability in the trypan blue test. In earlier work with chlorpyrifos, we found that inhibition of cell growth can occur, but only at higher concentrations than those used here ([@b73-ehp0115-000093]). However, for the membrane/total protein ratio, the nonorganophosphate agents caused an initial reduction in differentiating cells; because this was superimposed on an increase in protein/DNA, the results are consistent with larger cell bodies. With continued exposure, this effect disappeared, and for three agents (chlorpyrifos, parathion, dieldrin), there were increases in the membrane/total protein ratio. Obviously, then, superimposed on the deficits in cell number, there are changes in membrane complexity as differentiation proceeds, in a manner consistent with targeting of intracellular organelles and/or neuritic outgrowth. As discussed for some of the other findings, resolution of these issues requires morphologic determinations, which are thus not amenable to rapid screening; at the same time, the fact that these types of changes are detectable at the biochemical level lends support to the use of such indices. Notably, these measures strengthen the view that there are distinct differences among the various organophosphates, with diazinon showing unique properties; yet, at the same time, there is a resemblance of outcomes between some of the organophosphates and developmental neurotoxicants from different classes of compounds.

We conducted two additional sets of studies in differentiating cells that reinforce these conclusions. First, we examined TBARS as an index of lipid peroxidation with the idea that oxidative stress and resultant membrane damage could represent a common mechanism underlying the neurotoxicant actions of otherwise disparate compounds, especially in light of the prominence of oxidative stress in the noncholinesterase-related targets of organophosphates ([@b30-ehp0115-000093]). Indeed, all of the agents except Ni^2+^ showed a significant increase in TBARS after 6 days in culture. Uniquely, Ni^2+^ reduced TBARS, perhaps because nickel can exist in higher oxidation states, thus acting as a reductant in the culture system. Accordingly, taken in isolation, lipid peroxidation cannot explain commonalities between neurotoxicant end points of Ni^2+^ and the other agents. Nevertheless, it should be noted that earlier effects may go unnoticed and that we did not assess oxidative damage to cellular components other than membrane lipids (e.g., DNA). Again, the principle is that we are examining those aspects of neurodevelopment that lend themselves to rapid screening rather than investigating every potential mechanism of action.

The second set of studies concerned effects on the neurotransmitter phenotypic fate of the cells. In earlier work, we found that both chlorpyrifos and physostigmine suppress the expression of the cholinergic phenotype in favor of the catecholaminergic phenotype, thus raising the TH/ChAT ratio ([@b38-ehp0115-000093]). The same change in catecholaminergic/cholinergic balance occurs with chlorpyrifos treatment *in vivo* ([@b23-ehp0115-000093]; [@b49-ehp0115-000093]; [@b64-ehp0115-000093]; [@b70-ehp0115-000093]). Here, we found the same effects for all of the agents, with Ni^2+^ producing the largest shift in phenotype. Given the disparate nature of the various compounds tested here, it is highly unlikely that they all share the same specific targeting of gene promoters for the two phenotypes and rather, it appears that the cholinergic phenotype is simply far more vulnerable to neurotoxicant actions than is the catecholaminergic phenotype. In turn, this may explain why a wide variety of developmental neurotoxicants all seem to produce a similar pattern of cognitive defects that center around cholinergic synaptic function in key areas such as the hippocampus ([@b25-ehp0115-000093]; [@b33-ehp0115-000093]; [@b52-ehp0115-000093]; [@b64-ehp0115-000093]; [@b89-ehp0115-000093]; [@b97-ehp0115-000093], [@b96-ehp0115-000093]). The TH/ChAT index also supports the ability of the PC12 test system to readily distinguish toxicant effects that alter transmitter choice during neural cell differentiation, an effect that could readily contribute to the "miswiring" of key brain areas and resultant neurobehavioral deficits.

In conclusion, our results show the utility of the PC12 cell model as a potential screen for developmental neurotoxicants. This cell line allows for distinctions to be made between effects exerted on cell replication as compared to the more complex panoply of events occurring during differentiation, and can be applied to completely different classes of compounds. For the agents examined here, we were able to distinguish rank-order effects among different organophosphates and similarities and differences from a carbamate, which, although not an organophosphate, shares the ability to inhibit cholinesterase. Perhaps equally valuable, we showed how many features of developmental neurotoxicity are shared by an organochlorine (dieldrin) and a metal (Ni^2+^), thus leading to a number of predictions about the effects of these agents on brain development that can be tested *in vivo*. Nevertheless, it is important to distinguish between the use of cell lines that may be useful for screening of neurotoxicants and the potential for high-throughput techniques that would actually be required to have an impact for evaluation of the developmental neurotoxicity of the thousands of new chemical entities released each year. With regard to the end points used here, the radiometric techniques would need to be replaced by optical methods that lend themselves to detection with assay robots; certainly, there are far more potential end points of interest than those evaluated in the present study, such as apoptosis, development of receptors and ion channels, and dendritic arborization. Nor would it suffice to use only the PC12 model, as other cell systems may be required to evaluate the panoply of potential neurotoxic effects. Instead, a stepwise screening procedure is likely to be the best approach ([@b17-ehp0115-000093]; [@b18-ehp0115-000093], [@b19-ehp0115-000093]; [@b65-ehp0115-000093]): cell culture results can be followed by rapid screening in lower organisms such as zebrafish ([@b45-ehp0115-000093]) and sea urchin ([@b13-ehp0115-000093]), thus reducing the number of chemicals that ultimately need to be tested in mammals and narrowing the focus to enable better detection of the likely targets and end points in the mammalian brain. The results presented here, even though they involve only a handful of test compounds and end points in a single cell line, demonstrate the feasibility of one step in the development of a rapid *in vitro* screening procedure that may ultimately enable this type of sequential approach to tackle the problem of evaluating the thousands of potentially neurotoxic chemicals in the environment.
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![DNA synthesis shown as disintegrations per minute (dpm; mean ± SE) of \[^3^H\]thymidine in (*A*) undifferentiated cells exposed to 5 μM of agent, (*B*) undifferentiated cells exposed to 30 μM, and (*C*) differentiating cells exposed to 30 μM and cotreated with NGF (note that scale in *C* differs from that in *A* and *B*). ANOVA across all treatments and time points (number of determinations for each condition): (*A*), treatment, *p* \< 0.0001; treatment × time, *p* \< 0.0001 (*n* = 6--18); (*B*), treatment, *p* \< 0.0001; treatment × time, *p* \< 0.0001 (*n* = 12--30); (*C*), treatment, *p* \< 0.0001; treatment × time, *p* \< 0.0001 (*n* = 12--30).\
\*Significantly different from the corresponding control value (*p* \< 0.05).](ehp0115-000093f1){#f1-ehp0115-000093}

![Indices of cell number and size (mean ± SE) in undifferentiated cells exposed to 30 μM of agent for 6 days. (*A*) DNA content. (*B*) Total protein/DNA ratio. (*C*) Membrane/total protein ratio. ANOVA across all treatments (number of determinations for each condition): (*A*) *p* \< 0.0001 (*n* = 5--10); (*B*) *p* \< 0.0001 (*n* = 5--10); (*C*) *p* \< 0.0004 (*n* = 5--10).\
\*Significantly different from the corresponding control value (*p* \< 0.05).](ehp0115-000093f2){#f2-ehp0115-000093}

![Indices of cell number and size (mean ± SE) in differentiating cells exposed to 30 μM of agent and cotreated with NGF. (*A*) DNA content. (*B*) Total protein/DNA ratio. (*C*) Membrane/total protein ratio (note the interrupted ordinate scale). ANOVA across all treatments and both time points (number of determinations for each condition): (*A*) treatment, *p* \< 0.0001; treatment × time, *p* \< 0.0001 (*n* = 10--22); (*B*) treatment, *p* \< 0.0001; treatment × time, *p* \< 0.0001 (*n* = 10--22); (*C*) treatment, *p* \< 0.004; treatment × time, *p* \< 0.0001 (*n* = 10--22).\
\*Significantly different from the corresponding control value (*p* \< 0.05).](ehp0115-000093f3){#f3-ehp0115-000093}

![Indices of viability, oxidative damage, and transmitter phenotype (mean ± SE) in differentiating cells exposed to 30 μM of agent and cotreated with NGF for 6 days. (*A*) Trypan blue staining. (*B*) TBARS (note the interrupted ordinate scale). (*C*) TH/ChAT activity ratio. ANOVA across all treatments (number of determinations for each condition) (*A*) not significant (*n* = 10--22); (*B*) *p* \< 0.0001 (*n* = 5--10); (*C*) *p* \< 0.0001 (*n* = 10--25).\
\*Significantly different from the corresponding control value (*p* \< 0.05).](ehp0115-000093f4){#f4-ehp0115-000093}
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